Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

NCT03894046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Acinetobacter Baumannii-calcoaceticus Complex
Hospital-acquired Bacterial Pneumonia
Ventilator-associated Bacterial Pneumonia
Bacteremia
Colistin Resistant ABC

Interventions

DRUG: Sulbactam
DRUG: Durlobactam
DRUG: Colistin
DRUG: Imipenem/Cilastatin 500 mg/500 mg

Sponsor

Entasis Therapeutics